LNWTC
ELV icon

Laird Norton Wetherby Trust Company’s Elevance Health ELV Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Buy
8,215
+738
+10% +$274K 0.06% 235
2026
Q1 		$2.19M Sell
7,477
-852
-10% -$280K 0.05% 302
2025
Q4 		$2.92M Buy
+8,329
New +$2.81M 0.06% 245

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Laird Norton Wetherby Trust Company's ELV Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company increased its Elevance Health (ELV) stake by 9.9% in Q2 2026, buying an estimated $274K and bringing the position to 8,215 shares worth $3.18M. The position accounts for 0.06% of the portfolio, ranked #235.

Laird Norton Wetherby Trust Company first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 8,215 shares of Elevance Health worth $3.18M as of Q2 2026.
  • Laird Norton Wetherby Trust Company bought 738 Elevance Health shares in Q2 2026, an estimated $274K.
  • Elevance Health made up 0.06% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #235 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.